Valuation : Xcelerate Inc.

Market Cap 94.93L 81.48L 76.29L 69.86L 1.32Cr 91Cr 1.32Cr 9.03Cr 3.53Cr 46Cr 3.56Cr 3.49Cr 151.23Cr P/E 2022
-16x
P/E 2023 -5.46x
Enterprise Value 1.07Cr 91.83L 85.97L 78.72L 1.48Cr 102.17Cr 1.49Cr 10Cr 3.98Cr 51Cr 4.02Cr 3.93Cr 170.42Cr EV / Sales 2022
-
EV / Sales 2023 1,50,04,302x
Free-Float
58.58%
Yield 2022 *
-
Yield 2023 -
1 day+7.87%
1 week+10.55%
Current month-11.29%
1 month+0.14%
3 months+11.68%
6 months-29.91%
Current year+25.71%
1 week 0.01
Extreme 0.01015
0.01
1 month 0.01
Extreme 0.0091
0.01
Current year 0.01
Extreme 0.0067
0.02
1 year 0.01
Extreme 0.0061
0.02
3 years 0.01
Extreme 0.0061
0.08
5 years 0.01
Extreme 0.0061
0.14
10 years 0
Extreme 0.0004
0.17
Manager TitleAgeSince
Chief Executive Officer - 01/05/2020
Chief Tech/Sci/R&D Officer - 04/09/2020
Director TitleAgeSince
Director/Board Member - 23/07/2020
Chairman - -
Director/Board Member - 04/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
+7.87%+10.55%-32.93%-86.71% 47.66L
-1.48%-0.78%+29.87%+38.03% 12TCr
-1.83%+3.02%+4.32%+53.45% 9.25TCr
-0.38%-0.64%-1.44%+57.96% 3.04TCr
-0.16%+1.18%+35.62%+84.76% 2.7TCr
+0.42%+1.09%-1.23%-5.42% 2.24TCr
-2.35%-0.29%+48.72%+260.70% 2.21TCr
+0.03%+4.93%-6.02%+21.17% 1.49TCr
-0.57%-1.95%-8.09%-9.45% 1.25TCr
-0.65%+0.91%+28.99%+77.80% 1.15TCr
Average -0.04%+1.51%+9.78%+49.23% 3.54TCr
Weighted average by Cap. -1.07%+2.05%+17.27%+57.39%

Financials

2022 2023
Net sales - 1.12 0.96 0.9 0.83 1.56 107.17 1.56 10.68 4.17 54.01 4.21 4.12 178.76
Net income -8L -7L -7L -6L -11.71L -8.07Cr -11.74L -80.38L -31.42L -4.07Cr -31.71L -31.03L -13Cr -27.51L -23.61L -22.11L -20.24L -38.13L -26Cr -38.24L -2.62Cr -1.02Cr -13Cr -1.03Cr -1.01Cr -44Cr
Net Debt 1L 97.22T 91.01T 83.34T 2L 1.08Cr 2L 10.78L 4L 54.51L 4L 4L 1.8Cr 12.05L 10.34L 10L 9L 16.7L 12Cr 16.75L 1.15Cr 44.82L 5.8Cr 45.23L 44.25L 19Cr
Logo Xcelerate Inc.
Xcelerate, Inc. is a healthcare services and products company. The Company is engaged in three separate but related businesses within the medical, health and wellness sectors. The Company is focused on the development of medical technology and virtual health services to help patients in developing countries meet their medical needs by extending the reach of physicians through the technology; the formulation, packaging and marketing of consumer health and beauty, clinically tested skin and hair care products, and owning and licensing the rights to various forms of medical equipment.
Employees
12
Date Price Change Volume
25/26/25 $0.0110 +7.87% 30,000
20/26/20 $0.0102 +2.21% 19,990
  1. Stock Market
  2. Stocks
  3. XCRT Stock